Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Thomas L. Schwartz, MD: Psychotropic Drug-Induced Weight Gain Alleviated with Orlistat: A Case Series
1
x
$
30.00
C. Philip O’Carroll, MD: Migraine And The Limbic System: Closing The Circle
1
x
$
30.00
K. Ranga Rama Krishnan, MB, ChB: Evidence-Based Mental Health
1
x
$
30.00
The 2018 Handbook of Psychotropic Drug Interactions
1
x
$
30.00
Incretin Mimetics (GLP-1 Agonists) as an Addition to the Psychopharmacology Armamentarium
1
x
$
30.00
Oral Antipsychotic Versus Long- Acting Injections Antipsychotic in Schizophrenia Spectrum Disorder: a Mirror Analysis in a Real-World Clinical Setting
1
x
$
30.00
Intravenous Magnesium for the Management of Chronic Pain: An Updated Review of the Literature
1
x
$
30.00
Suvorexant in the Treatment of Difficulty Falling and Staying Asleep (Insomnia)
1
x
$
30.00
ADHD-A Clinician’s Bird’s Eye View of Current Status and New Vistas!
1
x
$
30.00
C. Lindsay DeVane, PharmD: Risperidone in the Management of Psychiatric and Neurodegenerative Disease in the Elderly: An Update
1
x
$
30.00
Evidence-Based Treatment of Psychiatric Disorders with Comorbid Medical Illnesses: The Need for Large Simple Clinical Trials
1
x
$
30.00
Therapeutic Potential of Naltrexone in the Niche of Psychopharmacology
1
x
$
30.00
View Cart
Checkout
Home
binge eating
“Therapeutic Potential of Naltrexone in the Niche of Psychopharmacology” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Incretin Mimetics (GLP-1 Agonists) as an Addition to the Psychopharmacology Armamentarium
$
30.00
Add to cart
Details
Therapeutic Potential of Naltrexone in the Niche of Psychopharmacology
$
30.00
Add to cart
Details
Page load link
Go to Top
